Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mammon who wrote (11589)	10/17/2012 11:18:00 AM
From: LT2011	3 Recommendations Read Replies (1) \| Respond to of 13111

The more that this is an unfriendly deal for the stockholders the more it will become a trading stock for the financial investor(s). As much as we want PVCT to succeed for the benefit of those who are ill it's still about money for those who are investing in the IPO. If there is a lead pharma with a major stake in the IPO then my position will be different. Stock trading is only good for those who are well trained and do it for a living. I would venture to guess that most of us are not in that category. PVCT has been the land of promise for so long that it's hard to accept anymore promises. The only thing that matters is what the FDA says. Right now the FDA isn't saying anything. Your reference to a hidden agenda by me is not the first time you've mentioned that. Is there anything in my postings that would suggest that? My weighted average and amount owned has been posted more than once. I've never sold a single share and as of this moment I don't have any plans to sell. I almost get the feeling that you're trying to disqualify me as a poster. explain why you think this would become a trading stock. why is a trading stock a bad thing? why would people need an exit strategy when the immunology and phase II results have been so promising? do you have a hidden agenda?